The binding of immune complexes by the erythrocyte complement receptor 1 (CR1)

Immunopharmacology

Volumn 24, Issue 2, 1992, Pages 101-106

  Pascual, M ^a   Schifferli, J A ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Complement receptor 1 (CD 35); Erythrocyte; Immune complex

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT RECEPTOR; ENDOGENOUS COMPOUND;

ANTIGEN ANTIBODY COMPLEX; CONFERENCE PAPER; ERYTHROCYTE; HUMAN; HUMAN CELL; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIGEN-ANTIBODY COMPLEX; BINDING SITES; COMPLEMENT 1; COMPLEMENT 1R; COMPLEMENT 3B; ERYTHROCYTES; NEUTROPHILS; SUPPORT, NON-U.S. GOV'T;

EID: 0026498826     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(92)90016-6     Document Type: Article

References (32)

1. An antipeptide antibody that recognizes a neoantigen in the CR1 stump remaining on E after proteolysis
2. Localization of monoclonal antibody epitopes on CR1 by deletion mutagenesis
3. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates
4. Immune complex bind preferentially to specific subpopulations of human erythrocytes
5. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates
6. Complement receptor type 1 (C3b/C4b receptor; CD 35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD 21)
7. The clearance of immune complexes from the circulation of man and other primates
8. The erythrocyte-immune complex-glomerulonephritis connection in man
9. Experimental immune complex-mediated glomerulonephritis in the non-human primate
10. Deficiencies of human complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21)
11. Erythrocyte clearance
12. Density Separation of human red blood cells on self forming Percoll gradients: correlation with age
13. Immune adherence of nascent hepatitis B surface antigen(HBsAg)/antibody complexes in vivo in humans
14. Immune complex binding efficiency of erythrocytes with different CR1 numbers or alleles
15. Defective immune adherence and elimination of hepatitis 3 surface Ag/Ab complexes in patients with mixed essential cryoglobulinaemia type II
16. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE)
17. Abnormal immune adherence and elimination of HBs Ag/Ab complexes in patients with acquired immunodeficiency syndrome
18. Nussenzweig. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes
19. The immune adherence phenomenon: an immunologically specific reaction between micro-organisms and erythrocytes leading to enhanced phagocytosis
20. The immune adherence phenomenon. A hypothetical role of erythrocytes in defence against bacteria and viruses
21. Direct evidence for the clustered nature of complement receptors type l (CR1) on the erythrocyte membrane
22. Difference in the clustering of complement receptor type 1 (CR1) on poly-morphonuclear leucocytes and erythrocytes: effect on immune adherence
23. CR1 on neutrophils aggregate after exsudation
24. NAP-1 / IL-8 induces upregulation of CR1 receptors in human neutrophil leucocytes
25. Release of vesicles enriched in CR1 from human erythrocytes during ATP-depletion
26. Overestimation of the number of complement receptor type l (CR1) on erythrocytes
27. Loss of complement receptor type 1 (CR1) on ageing of erythrocytes
28. Etude par la microcinématographie en contraste de phase et à l'accéléré du phénomène d'adherence et de la phagocytose secondaire
29. The clearance of tetanus toxoid- anti tetanus toxoid immune complexes from the circulation of humans: complement- and erythrocyte CR1-dependent mechanisms
30. The role of hypocomplementaemia and low erythrocyte complement receptor 1 numbers in determining abnormal immune complex clearance in humans
31. Physiological and pathological aspects of circulating immune complexes
32. Complementopsonized IgG antibody/dsDNS immune complexes bind to CR1 clusters on isolated human erythrocytes